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The formation of the dorsoventral (DV) boundary is central to
establishing the body plan in embryonic development. Although
there is some information about how limbs are positioned along
the DV axis and how DV skin color pattern is determined, the way
in which mammary glands are positioned is unknown. Here we
focus on Bmp4 and Tbx3, a gene associated with ulnar-mammary
syndrome, and compare their expression along the DV axis in
relation to mammary gland initiation in mouse embryos. Tbx3 is
expressed in the mammary gland-forming region with Tbx15, a
gene involved in a DV coat color being expressed more dorsally and
Bmp4 being expressed more ventrally. When Tbx3 was overex-
pressed, formation of mammary gland epithelium was extended
along the DV axis. In contrast, overexpression of Bmp4 inhibited
both Tbx3 and Tbx15 expression. In addition, when BMP signaling
was inhibited by NOGGIN, Lef1 expression was lost. Thus, we
propose that mutual interactions between Bmp4 and Tbx3 deter-
mine the presumptive DV boundary and formation of mammary
glands in early mouse embryogenesis. 1,19-Dioctadecyl-3,3,39,39-
tetramethyl indocarbocyanine perchloride labeling experiments
showed that cells associated with mammary glands originate more
dorsally and then move ventrally. This finding, together with
previous findings, suggests that the same DV boundary may not
only position limbs and determine coat color but also position
mammary glands. Furthermore, Bmp signaling appears to be a
fundamental feature of DV patterning.
dorsoventral patterning  ulnar-mammary syndrome
A key event in vertebrate embryogenesis is establishment ofthe main body axes, anteroposterior (head to tail) and
dorsoventral (DV; back to front), and specifying cell position
along them to give the body plan. One mechanism for specifying
cell position is through the response to gradients of various
extracellular signaling molecules (1). Positional information is
then encoded by expression of transcription factors that control
subsequent development of that region of the embryo, and this
ensures that organs are initiated in the correct locations. Striking
examples of organs that develop at a particular DV level are the
mammary glands (2). These arise alongmammary lines that form
at the boundary between anterior and lateral cutaneous nerve
branches (3, 4) and run in an anteroposterior direction between
forelimb and hindlimb (5, 6). These mammary lines are mor-
phologically evident in the flank (interlimb region) of rabbit
embryos and aremarked by expression of several different genes,
including Lef1 and Wnt10b, in mouse embryos (7). Here we
examine mammary gland initiation and positioning with respect
to DV body patterning in mouse embryos and examine the roles
of Bmp signaling and genes that encode Tbx transcription
factors.
Several aspects of DV body patterning have already been well
documented, and some of the key molecules have been identi-
fied. DV patterning of the mesoderm in early embryos leads to
tissue-specific differentiation. For example, dorsal explants from
early frog embryos differentiate into muscle, and ventral ex-
plants form blood (8). In the embryo, mesoderm becomes
regionalized to give somites, intermediate mesoderm, and lateral
plate mesoderm, going from dorsal to ventral (9). DV body
patterning is also crucial for positioning the limbs at the sides of
the body. This positioning is accomplished by formation of the
apical ectodermal ridge, the thickened epithelium required for
limb bud outgrowth, at a DV compartment boundary in the body
ectoderm (10). Yet another striking outcome of DV patterning
is the difference between back and belly skin or coat color (11).
Bmp signaling has been implicated in several of these examples.
Thus, graded Bmp signaling specifies mesoderm pattern in early
Xenopus embryos with high levels specifying ventral mesoderm,
which differentiates into blood (12).Mesodermal regionalization
in chicken embryos is also controlled by Bmp signaling with high
levels of Bmp4 signaling specifying ventral lateral plate meso-
derm (9). Finally, in ventral limb ectoderm, Bmp signaling acts
upstream of the gene encoding the transcription factor En-
grailed, which is required for proper DV patterning of the
limb (13).
Several members of the T-box transcription factor family
have been implicated in encoding position in embryos, and
Tbx15 has been shown to play a role in DV specification of skin
or coat color. In the absence of Tbx15 there is dorsal displace-
ment of yellow belly hair in agouti black and tan mice (11).
Interestingly, another Tbx gene, Tbx3, is associated with
mammary gland development. Haploinsufficiency of Tbx3 has
been associated with ulnar-mammary syndrome (UMS) in
human patients (14). UMS is an inherited disorder character-
ized by deficiencies in the ulnar ray in the upper limb and
hypoplasia of the mammary glands. In Tbx3/mouse embryos
there is almost complete failure of initiation of mammary
gland development (15).
One attractive possibility is that molecular mechanisms similar
to those involved in other aspects of DV patterning are used in
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formation of the mammary glands. Therefore, we first compared
expression patterns of Bmp4 and Tbx3 with respect to the DV
boundary of the body where mammary gland development is
initiated and then tested their involvement in mammary gland
positioning. The results have implications for understanding how
UMS arises during embryonic development and for the hypoth-
esis that Bmp signaling and Tbx gene transcription factors are
fundamental to DV patterning of the body.
Results
Gene Expression in Relation to the DV Position of Mammary Gland
Development. In mice, five individual mammary glands (num-
bered 1–5 from anterior to posterior) form along two mammary
lines running down each side of the ventral region of the body.
In embryonic day 10.5 (E10.5) embryos, an epithelial thickening
forms in the flank between the forelimb bud and the posterior
hindlimb bud (Fig. 1 K and K). At E11.5 the third mammary
placode is first detected as epithelial thickening (Fig. 1 Q and
Q), and over the next day the remaining four mammary
placodes form. These epithelial thickenings then grow down into
the underlying mesenchyme to form bud-like structures (6, 16).
Bmp4,Lef1, Tbx3, Tbx15, andWnt10b gene expression patterns
were documented with respect to mammary gland development
and the DV boundary in E10.5 and E11.5 mouse embryos using
whole-mount in situ hybridization (Fig. 1 A–J). To determine the
precise boundaries of expression of individual genes and to
compare precisely expression patterns of different genes, section
in situ hybridization methods were used and adjacent serial
Fig. 1. Gene expression patterns of Lef1, Bmp4, Tbx3, Tbx15, and Wnt10b in the flank around the time of mammary gland initiation at E10.5 and E11.5. (A–J)
Whole-mount in situ hybridization. (K–V and K–V) Section in situ hybridization showing the expression of each gene in serial sections of the same embryo.
Histological sections of the mammary gland-forming area at E10.5 (K and K) and E11.5 (Q and Q) mouse embryos are shown. (A–E, K–P, and K–P) E10.5. (A)
Bmp4 expressed in the ventral flank. (L and L) Bmp4 expression detected in the flank mesenchyme. (B) Broad Lef1 expression seen in the flank. (M and M) Lef1
was also expressed in the ventral and dorsal regions of the flank. (C) Tbx3 was strongly expressed in the anterodorsal region and was expressed in a broad band
in the flank. (N and N) A Tbx3 section showing expression in both the epithelium and mesenchyme. (D) Tbx15 expressed in the anterodorsal part of the body.
(O andO) Tbx15 expressed in the mesenchyme. (E, P, and P)Wnt10b expression was not detected in the flank. (F–J,Q–V, andQ–V) E11.5. (F) Bmp4was strongly
expressed in the ventral region. (R and R) Bmp4 was strongly expressed in both the epithelium and underlying mesenchyme of the ventral flank. (G, S, and S)
Restricted Lef1 expression was observed in the epithelium of the third mammary bud (arrowheads) at E11.5. (H, T, and T) Tbx3 was expressed in the epithelium
and mesenchyme underlying the third mammary bud (arrows). (I) Tbx15 expressed in the dorsal band. (V and V) Tbx15 expressed in the dorsal flank beneath
the mesenchyme at E11.5. (J,V, andV)Wnt10bwas expressed in the epithelium of the mammary buds. Red dotted boxes indicate areas of higher magnification.
Black arrowheads indicate mammary glands (MG1, MG3, and MG4). Asterisks indicate epithelial thickening in a region where the third mammary gland (MG3)
will form. Red arrows indicate mesenchymal condensation. Black arrows indicate strong mRNA expressions. (Scale bars: 125 m.)














sections were examined (Fig. 1 L–P, L–V, R–V, and R–V). At
E10.5 Lef1 was detected in both ventral and dorsal regions of the
flank (Fig. 1 B, M, and M) whereas Bmp4 expression in the
ectoderm and underlying mesenchyme was observed ventrally
(Fig. 1A,L, andL). Tbx3was expressed in a broad band all along
the anteroposterior axis of the flank between forelimb and
hindlimb (Fig. 1C), with strong expression in the thickened
epithelium that forms the mammary line and underlying mes-
enchyme (Fig. 1 N and N). Tbx15 was expressed in the dorsal
region of the flank between forelimb and hindlimb in epithelium
and underlying mesenchyme (Fig. 1 D, O, and O). Wnt10b was
not detected in the flank region of the E10.5 embryos (Fig. 1 E,
P, and P). At E11.5 Lef1 was expressed in the discrete epithelial
thickening, which is the earliest sign of the third mammary bud
(Fig. 1 G, S, and S) whereas Bmp4 was still expressed in both
ventral epithelium and underlying mesenchyme (Fig. 1F). Com-
pared with E10.5, Bmp4 expression was much stronger in the
epithelium and weaker in the mesenchyme (Fig. 1 R and R). At
E11.5 the intensity of Tbx3 expression was much higher than
E10.5 (Fig. 1H). Section in situ hybridization showed that Tbx3
is expressed in both epithelium and mesenchyme in the area in
which the third mammary bud is forming (Fig. 1 T and T)
whereas Tbx15 expression was dorsal and restricted to mesen-
chyme just beneath epithelium (Fig. 1 I, U, and U). At E11.5
Wnt10b expression was observed not only in the third mammary
gland (MG3) but also in the first (MG1) and fourth (MG4)
mammary glands (Fig. 1 J, V, and V).
Bmp4 and Tbx3 Play Key Roles in DV Patterning of Mammary Glands.
To test the interactions between Bmp4 and Tbx3 we electropo-
rated expression constructs containing either Bmp4 or Tbx3
together with a fluorescent reporter protein into themouse flank
Fig. 2. Mammary gland initiation after manipulation ofBmp4 signaling andTbx3. (A–E) Whole mount in situhybridization after electroporation of E10.0 mouse
embryo with a vector containing only fluorescent protein into the right flank. (F–U) Overexpression of Bmp4–pEGFP-N1 and Tbx3–pIRES-DsRed in the ventral
flank posterior to the regions of the forelimb bud. The left flank of each E10.0 embryo was used as the experimental side, and the right flank was used as the
control. (A–U) In vitro organ culture for 48 h and whole-mount in situ hybridization after electroporation. (A–U) Transverse sections after in situ hybridization
of in vitro organ cultured tissue. (F–U) Dark-field views of ectopic GFP expression (F–M) and of DsRed (N–U). (F–M and F–M) Overexpression of Bmp4. (G and
G) Lef1 expression in the dorsal mesenchyme induced by Bmp4 overexpression in the flank. (I, I, K, and K) Expression of Tbx3 and Tbx15 was reduced by Bmp4
overexpression. (M and M) Wnt10b expression; no change after Bmp4 overexpression. (N–U and N–U) Tbx3 overexpression. (O and O) Lef1 expression was
increased and was more widely expressed, and the epithelium was thickened. (Q and Q) Bmp4 expression was reduced by Tbx3 overexpression. (S and S) Tbx15
expression extended more ventrally in the flank when Tbx3 was overexpressed. (M, M, U, and U) Wnt10b was expressed throughout the whole depth of the
mesenchyme in the mammary gland-forming area after Tbx3 overexpression. (V, V, W, and W) Effect of NOGGIN on gene expression in the developing flank
at E10.0. (V and W) In vitro organ cultures 48 h after implanting NOGGIN (V) and PBS-soaked beads (W) to the flank posterior to the forelimb in E10.0 embryos
after whole-mount in situ hybridization for Lef1. (V and W) Section through beads. (V and V) Lef1 was inhibited in the region around the NOGGIN bead and
in the third mammary bud. (W and W) No changes in the Lef1 expression pattern in the flank or third mammary bud were observed (arrow). The yellow dotted
line indicates the limb. FL, forelimb; HL, hindlimb. The red dotted line indicates the basement membrane of epithelial thickening. The black dotted line indicates
the section level. The white dotted line indicates the outlining of embryo. The point of each arrowhead indicates dorsal direction. The open arrows indicate the
ventral margin of the somite region. The filled arrows in G indicate the mesenchymal Lef1 ectopic expression after Bmp4 overexpression. (Scale bars: 150 m.)
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posterior to the forelimb at E10.0, and the electroporated mouse
flank was then placed in in vitro organ culture for 48 h.
Expression patterns of Lef1, Bmp4, Tbx3, Tbx15, and Wnt10b
were then examined to elucidate the signaling network that
specifies the formation of mammary glands. Fig. 2 A–E and
A–E shows expression of these genes in controls in which only
the vector expressing fluorescent protein was electroporated.
After overexpression of both Bmp4 (Fig. 2 F, H, J, and L) and
Tbx3 (Fig. 2 N, P, R, and T), Lef1 expression increased in the
flank (Fig. 2 G and O). Transverse sections showed that, after
Tbx3 overexpression in the flank, the thickened epithelium
expressing Lef1 was dorsally extended toward the somite-
forming region and dorsal midline (n 2630; 86.7%) (Fig. 2O)
rather than being a discrete epithelial thickening expressing Lef1
as in the control third mammary bud. In four cases the thickened
epithelium appeared to be extended bidirectionally. The sections
also confirmed that the intensity of Lef1 expression was more
pronounced than in controls (compare Fig. 2 B, G, and O). In
contrast, Bmp4 overexpression did not alter the morphogenesis
of the mammary gland-forming epithelium, and only the discrete
thickening associated with the third mammary bud was present
(n  3030; 100%) (Fig. 2G).
To examine further the regulation of Lef1 by Bmp4, beads
soaked in the Bmp antagonist NOGGIN were implanted pos-
terior to the forelimb in E10.0 mouse embryo flank and then
cultured for 48 h. This application of NOGGIN resulted in local
inhibition of Lef1 expression (n  30; frequency of inhibition
70%) (Fig. 2 V and V). As controls, beads soaked in PBS were
implanted (n  30), and in these cultures Lef1 expression was
unaffected (Fig. 2 W and W). These data confirm that Bmps
regulate Lef1 expression. Thus both Tbx3 and Bmp4 appear to
play key roles in mammary gland initiation by regulating Lef1
expression.
Lef1 and Wnt10b expression patterns were similar in early
mammary gland development, with the genes being expressed in
a raised streak of lateral body wall epithelium at E11.5 (Fig. 1G,
J, S, S, V, and V). However, after Tbx3 and Bmp4 overexpres-
sion, expression of Wnt10b did not respond in the same way as
expression of Lef1. Thus,Wnt10b expression was not changed by
Bmp4 overexpression (n  2630; 86.7%) (Fig. 2 M and M)
Fig. 3. Tracing cell movement by DiI microinjection. (A) DiI injected into the
ventral–lateral flank posterior to the forelimb bud of E10.0. (B) After culturing
the flank for 72 h in in vitro organ culture DiI labeling was monitored to trace
the fate of marked cells. (C) Schematic diagrams showing experiments and
results together with the location of the mammary glands. FL, forelimb; HL,
hindlimb. Red spots, DiI; blue spots, mammary buds; yellow arrows, displace-
ment of DiI-labeled cells. (Scale bars: 125 m.)
Fig. 4. Schematic diagrams showing position-dependent patterns of gene expression along the DV body axis (A), interactions controlling the position of
mammary gland development at E11.5 (B), and a comparison of DV patterning with respect to the mammary glands, coat color, and limbs (C). (A) Transverse
section showing patterns of gene expression in relation to the DV axis. (B) Regulatory gene interactions that establish DV patterns of gene expression at E11.5
in the mammary gland-forming region and govern the position of mammary gland initiation. Note that it was not elucidated whether these interactions are
direct or indirect. (C) Lateral view of the flank showing interactions. (a) Positioning the mammary glands. (b) Determining coat color boundary. (c) Positioning
the limbs. Note that although three separate DV boundaries are shown, these may be the same boundary that is displaced ventrally over time. D, dorsal; V, ventral;
M, medial; L, lateral.














whereas, in contrast, after Tbx3 overexpression Wnt10b was
expressed not only in the epithelium but also in the whole depth
of mesenchyme under the third mammary gland-forming area
(n  2930; 96.6%) (Fig. 2 E, E, U, and U).
Bmp4 overexpression led to changes in Tbx3 and Tbx15
expression patterns (Fig. 2 I, I, K, and K). Overexpression of
Bmp4 completely abolished Tbx15 expression in the flank region
(n  3030; 100%) (Fig. 2 K and K), and Tbx3 expression was
almost completely inhibited except in the mesenchyme along the
DV border between the somite-forming area and dorsal f lank
(n  2930; 96.6%) (Fig. 2 I and I). These results suggest that
Bmp4 signaling regulates the extent of expression of T-box genes
along the DV axis of the flank.
There were also changes in Tbx15 and Bmp4 expression after
Tbx3 overexpression (n 3030; 100%) (Fig. 2Q,Q, S, and S).
Tbx15 expression was expanded into both dorsal and ventral
mesenchyme at the site of the epithelial thickening that marked
the mammary line (compare Fig. 2 D, D, S, and S). Bmp4
expression, in contrast, was inhibited where Tbx3 was overex-
pressed in the flank region (n  3030; 100%) (compare Fig. 2
A, A, Q, and Q).
So what is the relationship between the DV boundary at which
the limbs develop and that at which mammary glands form? To
address this question, we used the lipophilic dye 1,19-
dioctadecyl-3,3,39,39-tetramethyl indocarbocyanine perchloride
(DiI) to follow cell fate during early mammary gland formation
(Fig. 3). We labeled cells with DiI in the flank just posterior to
the limb bud at the same DV level as the limb bud. After 72 h
of culture the patch of DiI-labeled cells had extended not only
posteriorly along the flank but also more ventrally to occupy the
area of the forming mammary glands (Fig. 3).
Discussion
From our results we propose a model for DV patterning of
mammary glands. We have shown that expression domains of
Bmp4, Lef1, Tbx3, Tbx15, and Wnt10b are specifically localized
to different DV levels around the body at the time when
mammary gland development is initiated at E11.5 (Fig. 4A).
Tbx3 is expressed in the epithelium of the mammary bud and the
mesenchyme underlying Lef1 and Wnt10b expression, which
marks the DV position at which mammary glands develop,
whereas Tbx15 and Bmp4 are expressed dorsally and ventrally,
respectively. These striking position-dependent patterns of gene
expression along the DV body axis just before and during early
mammary gland formation suggest that interactions between
these genes, in particular Bmp4 and Tbx3, might control body
patterning with respect to mammary gland formation.
We tested this hypothesis by overexpressing Bmp4 and Tbx3 in
cultured mouse flanks. Our overexpression experiments showed
that there is reciprocal negative regulation between Bmp4 and
Tbx3 (Fig. 4B) and that overexpression of Tbx3 could induceLef1
expression and produce a DV extension of the epithelial thick-
ening of the ectoderm characteristic of the mammary placode.
Thus, we propose that inhibitory effects of Bmp4 on Tbx3 might
establish a DV boundary, which would then serve to confineLef1
expression and thickened mammary epithelium to a particular
position with respect to the DV body axis. Our experiments with
NOGGIN suggest that Bmp signaling also plays a role in
maintaining Lef1 expression in the mammary placode.
How does Tbx3 induce Lef1 expression and a thickened mam-
mary placode? As in tooth development (17), Lef1 might direct
mesenchymal condensation and be involved in the Wnt pathway
that induces an epithelial thickening. Wnt10b and Wnt6 are ex-
pressed along the DV boundary of the flank and then become
confined to the mammary placodes (16, 18). Consistent with a role
for Wnt10b, we found that, when Tbx3 was overexpressed, Wnt10b
expression was increased in the mesenchyme of the mammary
ridge. Thus, Tbx3 may play a crucial role at the DV boundary by
controlling Wnt10b and Lef1 expression and mammary gland
initiation (Fig. 4B). These data are consistent with observations on
Tbx3/ mouse embryos, in which neither Lef1 nor Wnt10b could
be detected in the regions where mammary glands normally form
(15, 16). The proposed involvement of Tbx3 in both setting a DV
boundary of the body and initiating mammary gland development
could explainwhymammary glands fail to form inTbx3/ embryos
and why, in UMS, which is caused by Tbx3 haploinsufficiency,
mammary glands are reduced.
There are striking similarities between the mechanisms that
we propose for mammary gland positioning and those that
control DV coat color and position the limbs (Fig. 4C). We have
proposed that antagonistic interactions between Bmp4 and Tbx3
are involved in initiation of mammary gland formation at a
particular DV level (Fig. 4C). From this viewpoint, observations
onUMS human patients (19) together with absence of mammary
glands in Tbx3/ mouse embryos might be considered in terms
of ventralization of the flank. We have also shown that Bmp4
signaling inhibits expression of Tbx15, which has previously been
shown to specify dorsal coat color and have a complementary
expression pattern to En1 (Fig. 4C) (11). Work by others has
shown that, in the absence of Tbx15, the belly coat color extends
more dorsally and therefore again could be considered to be due
to (partial) ventralization of the flank (11). Finally, previous
work has shown that Bmp4 signaling upstream of En1 also
specifies the ventral ectodermal compartment and controls
ventral limb pattern (13). Limb bud development occurs much
earlier than mammary gland development, and, because fingers
can be dorsalized in some human patients with UMS (14, 19), we
suggest that, at this earlier stage, Tbx3 may act in concert with
Bmp4 to specify ventral limb pattern. Indeed, the importance of
Bmp signaling in maintaining Tbx3 expression in the developing
limb is well documented (20).
It is not clear whether the same DV boundary operates in all
three patterning processes. We have shown that cells that
participate in mammary gland formation originate more dorsally
and then become displaced ventrally. Furthermore, Tbx15 ex-
pression has been reported to extend more ventrally as devel-
opment proceeds. Therefore, it is possible that the same bound-
ary is used but by means of different target genes, including two
gene members of the Tbx family, and at successive times in
development.
Materials and Methods
All experiments were performed according to the guidelines of
the Intramural Animal Use and Care Committee of Yonsei
University College of Dentistry.
Animals. Adult Institute of Cancer Research mice were housed in
a temperature-controlled room (22°C) under artificial illumination
(lights on from 0500 to 1700 hours) and 55% relative humidity. The
mice had access to food and water ad libitum. Embryos were
obtained from time-mated pregnant mice. E0 was designated as the
day a vaginal plugwas confirmed. Embryos at developmental stages
E10.0, E10.5, and E11.5 were used in this study.
in Vitro Organ Culture. Institute of Cancer Research mouse em-
bryos were isolated at E10.0 and placed in culture medium
(BGJb; Sigma, St. Louis, MO) augmented with 0.5% penicillin
streptomycin and 0.2% ascorbic acid as previously described (6).
Briefly, individual embryos were dissected into left and right
halves by using fine tungsten needles to bisect the neural tube.
The left f lank was the experimental tissue, and the right acted
as control. Each flank tissue was placed on filter membranes
(Track-etch, 1.0-m pore; Whatman Nuclepore), which were
supported on stainless steel grids in sterile culture dishes, and
cultured at the air–medium interface at 37°C and 7.5% CO2 for
48 and 72 h. Culture medium was replaced at 24 h. Tissues were
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then fixed and processed for in situ hybridization. At least 30
explants were used in each experiment.
DiI Microinjection.DiI (Molecular Probes, Eugene, OR) is a vital,
highly fluorescent, lipophilic dye belonging to the carbocyanine
dye family. After DiI microinjection into designated regions of
the flank, the migration pattern of DiI-labeled cells was ob-
served at 72 h by using fluorescence microscopy (MZ-FLIII;
LEICA, Jena, Germany).
In Situ Hybridization. In situ hybridization was performed as
previously described by Kim et al. (21). Section in situ hybrid-
ization was performed as previously described on wax sections by
using standard protocols (21). Briefly, embryos were fixed in 4%
paraformaldehyde, embedded in paraffin wax, and sectioned at
12 m. The following DNA plasmids were used as templates for
the synthesis of digoxigenin-labeled RNA probes: Bmp4 and
Lef1 (from Yi-Ping Chen, Tulane University, New Orleans, LA);
Tbx3 and Tbx15 (from Gregory S. Barsh, Stanford University
School of Medicine, Stanford, CA); and Wnt10b.
Bead Implantation. Affigel Blue beads (Bio-Rad), 150 m in
diameter, were washed with PBS and then soaked in 0.5 mgml
human recombinant NOGGIN (Regeneron). Beads were im-
planted in the flank region along the mammary line of E10.0
mouse embryos.
Expression Constructs. Constructs were pEGFP-N1 and pIRES-
DsRed, both of which have been optimized for generating
proteins with brighter fluorescence (Clontech). Bmp4 was in-
serted into the blunted EcoRIHindIII sites of pEGFP-N1, and
Tbx3 was inserted into the XhoIBamHI sites of pIRES-DsRed.
Electroporation. Plasmid DNA was purified by using a plasmid
purification kit (Qiagen, Valencia, CA) and dissolved in T14E
(10 mM TrisHCl, pH 8.00.25 mM EDTA). Fast Green at
110,000 (Sigma) was added to the DNA solution for visualiza-
tion within the tissue. A microcapillary needle was used to inject
1 gl DNA into the flank mesenchyme, after which 20-ms
current pulses of 25 V were applied with an electroporator. The
experimental group comprised the left f lank electroporated with
either Bmp4 in pEGFP-N1 or Tbx3 in pIRES-DsRed construct.
The right flank was electroporated with constructs containing
only fluorescent proteins (EGFP and DsRed) and used as
controls.
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